Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many prescriptions were issued for each drug categorised under the (a) (i) clonazepam and (ii) other benzodiazepines, (b) z-drugs, (c) antidepressants, (d) opioids, (e) pregabalin and (f) gabapentin drug groups in the (i) last 12 months and (ii) previous 12 month period for which data is available.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The following table shows the number of items dispensed and claimed for reimbursement for each of the categories requested, covering the most recently published 12-month period and the 12 months prior:
Drug group | Financial year | Total number of items |
Clonazepam | 2022/23 | 1,048,081 |
2023/24 | 1,059,421 | |
Other benzodiazepines | 2022/23 | 7,156,845 |
2023/24 | 6,814,129 | |
Clonazepam and other benzodiazepines | 2022/23 | 8,204,926 |
2023/24 | 7,873,550 | |
Z-drugs | 2022/23 | 5,316,627 |
2023/24 | 5,113,574 | |
Antidepressants | 2022/23 | 86,263,722 |
2023/24 | 89,131,582 | |
Opioids | 2022/23 | 39,401,517 |
2023/24 | 39,046,206 | |
Pregabalin | 2022/23 | 8,775,699 |
2023/24 | 9,180,793 | |
Gabapentin | 2022/23 | 7,413,759 |
2023/24 | 7,408,375 |
Source: NHS Business Services Authority.
In addition, the following table shows the patient identifiable information for the number of items dispensed and claimed for reimbursement for each of the categories requested, for the most recently published 12-month period and the 12 months prior:
Drug group | Financial Year | Total number of unique identified patients | Percentage of items where the patient has been identified |
Clonazepam | 2022/23 | 85,613 | 98.22% |
2023/24 | 85,191 | 98.16% | |
Other benzodiazepines | 2022/23 | 1,253,962 | 97.06% |
2023/24 | 1,186,001 | 97.01% | |
Clonazepam and other benzodiazepines | 2022/23 | 1,324,792 | 97.21% |
2023/24 | 1,256,941 | 97.17% | |
Z-drugs | 2022/23 | 795,959 |
|
2023/24 | 764,743 |
| |
Antidepressants | 2022/23 | 8,563,148 |
|
2023/24 | 8,747,095 |
| |
Opioids | 2022/23 | 5,593,035 |
|
2023/24 | 5,562,718 |
| |
Pregabalin | 2022/23 | 786,403 |
|
2023/24 | 823,231 |
| |
Gabapentin | 2022/23 | 808,562 |
|
2023/24 | 799,144 |
|
Source: NHS Business Services Authority.
Notes:
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the impact of the restriction of puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
On 11 December 2024 the Government introduced The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024, which came into effect on 1 January 2025. Alongside this legislation the Government published a full impact assessment, which is available at the following link:
https://www.legislation.gov.uk/uksi/2024/1319/impacts
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many public health representatives he has met to discuss (a) tobacco, (b) obesity and (c) alcohol harm; and whether he plans to meet more public health organisations in the New Year to discuss those issues.
Answered by Andrew Gwynne
Details of ministers’ meetings with external individuals and organisations are published quarterly in arrears on GOV.UK website. Data for the period of July to September 2024 will be published in due course.
I can confirm that Department ministers expect to continue to engage with prevention and public health stakeholders across a number of important issues next year.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many alcohol industry representatives Ministers in his Department have met since July 2024.
Answered by Andrew Gwynne
Details of ministers’ meetings with external individuals and organisations are published quarterly in arrears on GOV.UK website. Data for the period of July to September 2024 will be published in due course.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he plans to take to tackle alcohol harms.
Answered by Andrew Gwynne
Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. For too long there has been an unwillingness to lead on issues like smoking, alcohol harm, and obesity. It is unacceptable that alcohol deaths are now at record high levels. The Department will continue to work across Government to understand how we can best reduce alcohol-related harms.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps the Health Mission Board has taken to tackle rates of alcohol harm.
Answered by Andrew Gwynne
Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. For too long there has been an unwillingness to lead on issues like smoking, alcohol harm, and obesity. It is unacceptable that alcohol deaths are now at record high levels. The Department will continue to work across Government to understand how we can best reduce alcohol-related harms.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to meet (a) the Alcohol Health Alliance and (b) other public health representatives to discuss rates of alcohol harm.
Answered by Andrew Gwynne
Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. For too long there has been an unwillingness to lead on issues like smoking, alcohol harm, and obesity. It is unacceptable that alcohol deaths are now at record high levels. I can confirm that Department ministers plan to meet representatives from the Alcohol Health Alliance in the new year.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will meet the Alcohol Health Alliance to discuss what steps the Government can take to reduce alcohol related deaths.
Answered by Andrew Gwynne
Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. For too long there has been an unwillingness to lead on issues like smoking, alcohol harm, and obesity. It is unacceptable that alcohol deaths are now at record high levels. I can confirm that Department ministers plan to meet representatives from the Alcohol Health Alliance in the new year.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to announce the future funding for drug and alcohol treatment provision as part of the Drugs Strategy in time for services to avoid commencing redundancy consultations; and if he will change future treatment funding announcement cycles to give local authorities more time to (a) plan and (b) commission such services.
Answered by Andrew Gwynne
The Government supports investment in drug and alcohol treatment and recovery services, to ensure that those people with a substance use need get appropriate help and support. In addition to the Public Health Grant, the Department has allocated local authorities a further £267 million in 2024/25 to improve the quality and capacity of drug and alcohol treatment and recovery. This is alongside £105 million made available by the Department of Health and Social Care, the Department for Work and Pensions, and the Ministry of Housing, Communities and Local Government to improve employment and housing support.
My Rt. Hon. friend, the Chancellor of the Exchequer announced updates to the fiscal framework, and earlier this year launched the Spending Review which has now settled the 2025/26 departmental budgets. She has also made it clear that the Government will conclude a multi-year Spending Review in spring 2025. In future, we anticipate that Spending Reviews will be set every two years to cover a three-year period, including a one-year overlap with the previous Spending Review, helping build in greater certainty and stability over public finances.
Now that the Autumn Budget has been completed, the Department is working to be able to announce future funding allocations for drug and alcohol treatment and recovery systems. We will communicate with the sector about this as soon as we are able to, as we recognise the importance of this information in maintaining delivery and planning for 2025/26.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to announce (a) whether Drug Strategy funding for drug and alcohol treatment providers will be renewed and at what levels and (b) the length of the funding cycle; and if he will take steps to ensure that local authorities have adequate notice of alcohol and drug treatment funding.
Answered by Andrew Gwynne
The Government supports investment in drug and alcohol treatment and recovery services, to ensure that those people with a substance use need get appropriate help and support. In addition to the Public Health Grant, the Department has allocated local authorities a further £267 million in 2024/25 to improve the quality and capacity of drug and alcohol treatment and recovery. This is alongside £105 million made available by the Department of Health and Social Care, the Department for Work and Pensions, and the Ministry of Housing, Communities and Local Government to improve employment and housing support.
My Rt. Hon. friend, the Chancellor of the Exchequer announced updates to the fiscal framework, and earlier this year launched the Spending Review which has now settled the 2025/26 departmental budgets. She has also made it clear that the Government will conclude a multi-year Spending Review in spring 2025. In future, we anticipate that Spending Reviews will be set every two years to cover a three-year period, including a one-year overlap with the previous Spending Review, helping build in greater certainty and stability over public finances.
Now that the Autumn Budget has been completed, the Department is working to be able to announce future funding allocations for drug and alcohol treatment and recovery systems. We will communicate with the sector about this as soon as we are able to, as we recognise the importance of this information in maintaining delivery and planning for 2025/26.